Skip to content

Medical-device intelligence

JFM: Enzymatic Method, Bilirubin

FDA product code JFM: Enzymatic Method, Bilirubin. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
JFM
FDA device name
Enzymatic Method, Bilirubin
Device class
2
Regulation number
862.1110
Medical specialty
Clinical Chemistry
Review panel
CH

The source does not provide a definition for this entry. Consult the FDA classification and regulation reference for further detail.

Explore clinical chemistry records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

11 clearance records and 9 recall records in the covered releases, across 9 source company names and 1 product codes. Dated history runs from Sep 14, 1984 to Oct 11, 2023.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
JFM · Enzymatic Method, Bilirubin119

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

20 matching records
Device / recordCompany in FDA recordSourceSource date
RANDOX Total Bilirubin.Z-0501-2024 · JFMRandox Laboratories Ltd.RecallDec 6, 2023FDA classification date
Atellica CH Total Bilirubin_2 -In vitro diagnostic use in the quantitative determination of total bilirubin in human serum and plasma (lithium he…Z-2471-2023 · JFMSiemens Healthcare Diagnostics, Inc.RecallAug 28, 2023FDA classification date
Atellica CH LDL Cholesterol- In vitro diagnostic use in the quantitative determination of LDL cholesterol in human serum and plasma (lithium hepa…Z-2472-2023 · JFMSiemens Healthcare Diagnostics, Inc.RecallAug 28, 2023FDA classification date
Atellica CH Gamma-Glutamyl Transferase-IIn vitro diagnostic use in the quantitative determination of gamma-glutamyl transferase in human serum an…Z-2473-2023 · JFMSiemens Healthcare Diagnostics, Inc.RecallAug 28, 2023FDA classification date
Atellica CH HDL Cholesterol- In vitro diagnostic use in the quantitative determination of HDL cholesterol in human serum and plasma (lithium hep…Z-2474-2023 · JFMSiemens Healthcare Diagnostics, Inc.RecallAug 28, 2023FDA classification date
Atellica CH Direct Bilirubin_2 assay In vitro Diagnostic for the determination of direct bilirubin SMN: 11097532 - Product Usage: ADVIA DBIL_ 2 i…Z-1536-2020 · JFMSiemens Healthcare Diagnostics, Inc.RecallMar 20, 2020FDA record creation date
Atellica CH Total Bilirubin_2 assay-In vitro Diagnostic for the determination of total bilirubin SMN: 11097531 - Product Usage: Atellica TBil_2 …Z-1537-2020 · JFMSiemens Healthcare Diagnostics, Inc.RecallMar 20, 2020FDA record creation date
ADVIA Chemistry Direct Bilirubin_2 assay-SMN: 10316610 (20 mL) & 10341114 (70 mL) - Product Usage: ADVIA DBIL_ 2 is for in vitro diagnostic use …Z-1538-2020 · JFMSiemens Healthcare Diagnostics, Inc.RecallMar 20, 2020FDA record creation date
ADVIA Chemistry Total Bilirubin_2 assay- SMN: 10341115 (40 mL) & 10341113 (70 mL). Product Usage: ADVIA TBIL_2 is for in vitro diagnostic use …Z-1539-2020 · JFMSiemens Healthcare Diagnostics, Inc.RecallMar 20, 2020FDA record creation date
ADVIA® Chemistry Total Bilirubin_2 (TBIL_2)K170065 · JFMSiemens Healthcare Diagnostics, Inc.510(k)Mar 9, 2017FDA decision date
Direct BilirubinK152343 · JFMRandox Laboratories Limited510(k)Feb 16, 2016FDA decision date
Total BilirubinK152344 · JFMRandox Laboratories Limited510(k)Jan 28, 2016FDA decision date
ADVIA CHEMISTRY TOTAL BILIRUBIN_2K063845 · JFMBayer Healthcare, LLC510(k)Dec 7, 2007FDA decision date
WAKO TOTAL BILIRUBIN V, MODELS 410-22701, 998-23291, 416-22801, 990-23191K053131 · JFMWako Chemicals USA, Inc.510(k)Dec 30, 2005FDA decision date
WAKO DIRECT BILIRUBIN V, MODELS 996-23591, 412-22901, 992-23691, 998-23791K053132 · JFMWako Chemicals USA, Inc.510(k)Dec 30, 2005FDA decision date
DRI-STAT ENZYMATIC BILIRUBIN REAGENT, SYNCHRON SYSTEMS BILIRUBIN CALIBRATORK053090 · JFMBeckman Coulter, Inc.510(k)Dec 16, 2005FDA decision date
DIRECT BILIRUBIN LIQUICOLOR AND TOTAL BILIRUBIN LIQUICOLORK050266 · JFMStanbio Laboratory510(k)Jun 30, 2005FDA decision date
WAKO TOTAL BILIRUBIN VK970985 · JFMWako Chemicals USA, Inc.510(k)Apr 21, 1997FDA decision date
ENZYMATIC BILIRUBIN (TOTAL), CATALOGUE NO. 202-14K904660 · JFMDiagnostic Chemicals, Ltd. (Usa)510(k)Nov 20, 1990FDA decision date
DRI-STAT ENZYMATIC BILIRUBIN TEST KITK843174 · JFMBeckman Instruments, Inc.510(k)Sep 14, 1984FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗